RU2012105925A - Адаптированный к плазме сбалансированный раствор желатина - Google Patents
Адаптированный к плазме сбалансированный раствор желатина Download PDFInfo
- Publication number
- RU2012105925A RU2012105925A RU2012105925/15A RU2012105925A RU2012105925A RU 2012105925 A RU2012105925 A RU 2012105925A RU 2012105925/15 A RU2012105925/15 A RU 2012105925/15A RU 2012105925 A RU2012105925 A RU 2012105925A RU 2012105925 A RU2012105925 A RU 2012105925A
- Authority
- RU
- Russia
- Prior art keywords
- gelatin
- pharmaceutical composition
- composition according
- physiologically acceptable
- mmol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102009034132.3 | 2009-07-20 | ||
| DE102009034132A DE102009034132A1 (de) | 2009-07-20 | 2009-07-20 | Plasmaadaptierte und balancierte Gelatinelösung |
| PCT/EP2010/060210 WO2011009797A2 (de) | 2009-07-20 | 2010-07-15 | Plasmaadaptierte und balancierte gelatinelösung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2012105925A true RU2012105925A (ru) | 2013-08-27 |
Family
ID=43334706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012105925/15A RU2012105925A (ru) | 2009-07-20 | 2010-07-15 | Адаптированный к плазме сбалансированный раствор желатина |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2456446A2 (pt) |
| KR (1) | KR20120046160A (pt) |
| CN (1) | CN102470147A (pt) |
| BR (1) | BR112012001229A2 (pt) |
| DE (2) | DE102009034132A1 (pt) |
| IN (1) | IN2012DN00419A (pt) |
| MX (1) | MX2012000957A (pt) |
| RU (1) | RU2012105925A (pt) |
| WO (1) | WO2011009797A2 (pt) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2739561C2 (ru) * | 2016-07-26 | 2020-12-25 | Лара ОЛЛЕР ДУКЕ | Изотонический кристаллоидный водный раствор |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA702706B (en) * | 1969-04-28 | 1971-12-29 | Knox Gelatine Inc | Blood plasma substitute |
| EP0223906A3 (en) * | 1982-10-29 | 1989-02-01 | Synthetic Blood Corporation | Gelatin based synthetic whole blood and a process for preparing the same |
| EP1238675A1 (en) | 2001-03-06 | 2002-09-11 | Fuji Photo Film B.V. | Recombinant gelatin-like proteins for use as plasma expanders |
-
2009
- 2009-07-20 DE DE102009034132A patent/DE102009034132A1/de not_active Withdrawn
-
2010
- 2010-07-15 EP EP10734480A patent/EP2456446A2/de not_active Withdrawn
- 2010-07-15 DE DE202010018349.9U patent/DE202010018349U1/de not_active Expired - Lifetime
- 2010-07-15 WO PCT/EP2010/060210 patent/WO2011009797A2/de active Application Filing
- 2010-07-15 MX MX2012000957A patent/MX2012000957A/es not_active Application Discontinuation
- 2010-07-15 RU RU2012105925/15A patent/RU2012105925A/ru unknown
- 2010-07-15 BR BR112012001229A patent/BR112012001229A2/pt not_active IP Right Cessation
- 2010-07-15 CN CN2010800330764A patent/CN102470147A/zh active Pending
- 2010-07-15 KR KR1020127000796A patent/KR20120046160A/ko not_active Application Discontinuation
-
2012
- 2012-01-16 IN IN419DEN2012 patent/IN2012DN00419A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2739561C2 (ru) * | 2016-07-26 | 2020-12-25 | Лара ОЛЛЕР ДУКЕ | Изотонический кристаллоидный водный раствор |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2456446A2 (de) | 2012-05-30 |
| WO2011009797A2 (de) | 2011-01-27 |
| IN2012DN00419A (pt) | 2015-05-15 |
| KR20120046160A (ko) | 2012-05-09 |
| WO2011009797A3 (de) | 2011-08-25 |
| CN102470147A (zh) | 2012-05-23 |
| DE102009034132A1 (de) | 2011-01-27 |
| DE202010018349U1 (de) | 2015-10-28 |
| BR112012001229A2 (pt) | 2016-03-01 |
| MX2012000957A (es) | 2012-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Influence of peptide characteristics on their stability, intestinal transport, and in vitro bioavailability: A review | |
| JP2019504881A5 (pt) | ||
| Mahmoodani et al. | ACE inhibitory activity of pangasius catfish (Pangasius sutchi) skin and bone gelatin hydrolysate | |
| ES2781114T3 (es) | Composición proteica derivada de fibroína | |
| Lafarga et al. | A bovine fibrinogen-enriched fraction as a source of peptides with in vitro renin and angiotensin-i-converting enzyme inhibitory activities | |
| Cheng et al. | Identification and inhibitory activity against α-thrombin of a novel anticoagulant peptide derived from oyster (Crassostrea gigas) protein | |
| JP2006149365A5 (pt) | ||
| Fu et al. | Separation of angiotensin I‐converting enzyme inhibitory peptides from bovine connective tissue and their stability towards temperature, p H and digestive enzymes | |
| WO2011036445A3 (en) | Polypeptides and uses thereof | |
| JP2019533722A5 (pt) | ||
| WO2012069836A3 (en) | Biologically active complex and its preparation | |
| WO2006052821A3 (en) | Compositions and methods for treatment of protein misfolding and protein aggregation diseases | |
| RU2011140057A (ru) | Способ профилактики и лечения повышенной проницаемости | |
| JP2016511238A5 (pt) | ||
| CN102517366A (zh) | 一种鱼皮胶原蛋白酶解物及其制备方法、用途 | |
| NO20092360L (no) | Nye antiproliferasjonsantistoffer | |
| EA201100071A1 (ru) | Новые композиции и способы | |
| ATE517118T1 (de) | Bis-met-histone | |
| JP2011517450A5 (pt) | ||
| RU2016152151A (ru) | Препарат, содержащий фактор viii и пептиды фактора фон виллебранда | |
| RU2017101667A (ru) | Фармацевтические композиции | |
| JP2012244930A (ja) | かつおの中骨を原料とするコラーゲンペプチドの製造方法 | |
| EA201590601A1 (ru) | Применение pedf-производных полипептидов для лечения остеоартрита | |
| Wang et al. | Seafood processing by-products: collagen and gelatin | |
| RU2012105925A (ru) | Адаптированный к плазме сбалансированный раствор желатина |